Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Learn about the value of credit card points when purchasing gift cards. Make informed choices to maximize your rewards.
24,001 articlesEli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Palantir delivers a strong Q1, beating expectations with better profitability than many software peers, yet the stock...
A watershed moment hit crypto markets as bitcoin etfs shed $630m in one day. This article breaks down what drove the ...
Two AI bets with very different risk profiles surfaced as Microsoft and Palantir reported earnings. Microsoft leans o...
A health diagnosis that tilted retirement math retools how seniors claim Social Security and invest. This report expl...
Genius Sports reported a significant top-line gain, with revenue up sharply last quarter. But a prominent investor ch...
SpaceX is signaling a public debut that could rewrite IPO benchmarks, even as critics warn the proposed governance st...
SpaceX discloses a sizable Bitcoin treasury in an SEC filing, confirming 18,712 BTC valued at about $1.293 billion as...
If SpaceX ever files for an IPO, the prospectus would reveal the core drivers, the risks, and the questions investors...
A respected advisory firm recently trimmed its stake in Peabody Energy, nudging the stock and sparking questions abou...
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
Palantir stock is under pressure as AI enthusiasm wavers and growth expectations shift. This guide breaks down the re...